Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
FDA Compliance Group LLC is a compliance consulting and training provider for FDA-regulated industries. Its headquarters information indicates it is based in Broomfield, Colorado, USA. It is not a typical SaaS or enterprise software product; instead, its core offering is expert consulting, inspection support, submission assistance, and training for sectors such as medical devices, pharmaceuticals/OTC products, cosmetics, dietary supplements, clinical research, food and beverages, tobacco, and more.
Based on the site content, its services cover many key aspects of FDA/FTC compliance: FDA registration and submissions, including 510(k) and PMA; clinical trial support; labeling, advertising, and website compliance reviews; mock FDA audits and inspection preparation; gap analyses, recalls, MDR and adverse event reporting; SOP development and quality system implementation; responses to Form 483 observations and Warning Letters; expert witness services; inspection assistance and follow-up; compliance and quality system training; and M&A due diligence. Its main selling point is that the team includes former FDA professionals and industry subject-matter experts, enabling support across the product lifecycle from clinical development to commercialization and post-market regulatory oversight.
The website does not disclose fixed packages, software subscription pricing, a free trial, or payment methods; it only describes the services as “cost-effective.” This suggests pricing is more likely to be project-based, scoped according to consulting needs, or quoted based on expert services after an inquiry or phone consultation. Since it is not a software platform, the content also does not provide common enterprise software details such as cloud deployment, self-hosting, APIs, third-party integrations, or team permissions.
Its strengths lie in deep specialist expertise, especially for high-risk scenarios such as FDA inspection readiness, enforcement letter responses, quality systems, and regulatory submissions. It also covers a broad range of industries, making it suitable for companies operating across product categories or preparing for U.S. market compliance. The limitations are a lack of transparency: pricing, delivery timelines, project methodology, data security measures, and detailed case studies are not explained in the main content. It is also not a fit for teams looking to purchase a standardized software tool.
It is best suited for companies planning to enter the U.S. market, organizations facing an FDA inspection or responding to a Form 483/Warning Letter, and regulatory affairs teams that need to build quality systems, review labeling and advertising, or complete FDA submissions. The main content provides no information about access from China, so this remains unknown; payment methods are also not disclosed. Chinese companies considering the service should confirm the remote service workflow, time-zone communication, contract and payment arrangements, confidentiality of materials, and whether the team has relevant experience with their specific product category.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on fdacg.com official site.
fdacg.com is an United States Legal & Tax provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach fdacg.com directly.